Table 2.
Feature | Lung metastasis (n = 30) | Benign (n = 10) | P value |
Primary tumor site | 0.001 | ||
Colon | 4 (13.3) | 7 (70.0) | |
Rectum | 26 (86.6) | 3 (30.0) | |
Primary tumor size, cm | 5.2 ± 1.5 | 5.7 ± 2.9 | 0.505 |
T stage | 0.015 | ||
Tis | 0 | 1 (10.0) | |
T1 | 0 | 1 (10.0) | |
T2 | 1 (3.3) | 0 | |
T3 | 28 (93.3) | 5 (50.0) | |
T4 | 1 (3.3) | 3 (30.0) | |
N stage | 0.001 | ||
N0 | 5 (16.6) | 8 (80.0) | |
N1 | 17 (26.6) | 2 (20.0) | |
N2 | 8 (26.6) | 0 | |
TNM stage | 0.011 | ||
0 | 0 | 1 (10.0) | |
I | 1 (3.3) | 1 (10.0) | |
II | 3 (10.0) | 5 (50.0) | |
III | 16 (53.4) | 2 (20.0) | |
IV | 10 (33.3) | 1 (10.0) | |
Metastatic LN (n) | 33 ± 23 | 22 ± 9 | 0.034 |
LN ratio1 | 0.171 ± 0.155 | 0.031 ± 0.072 | 0.009 |
Histologic differentiation | 0.195 | ||
WD | 0 | 1 (10.0) | |
MD | 26 (86.6) | 8 (80.0) | |
PD | 3 (10.0) | 0 | |
Mucinous | 1 (3.3) | 1 (10.0) | |
Lymphatic invasion | 22 (73.3) | 2 (20.0) | 0.005 |
Vascular invasion | 4 (13.3) | 1 (10.0) | 0.633 |
Perineural invasion | 5 (16.6) | 1 (10.0) | 0.526 |
Adjuvant chemotherapy | 23 (76.7) | 3 (30.0) | 0.048 |
Involved LN (n)/total LN (n). LN: Lymph node; MD: Moderately differentiated; PD: Poorly differentiated; TNM: Tumor-node-metastasis; WD: Well differentiated.